Evidence map›Paper›PMID 22649188›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2012

Elevated hepatic iron activates NF-E2-related factor 2-regulated pathway in a dietary iron overload mouse model.

Mi Sun Moon, Emily I McDevitt, Junjia Zhu, Bruce Stanley, Jacek Krzeminski, Shantu Amin, Cesar Aliaga, Thomas G Miller, Harriet C Isom

Open access · bronzeAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Effects of acute iron overload on Nrf2-related glutathione metabolism in rat brain.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2021
    Article
  6. Article
  7. Article
  8. Iron-Induced Liver Injury: A Critical Reappraisal.International journal of molecular sciences · 2019
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Mi Sun MoonDepartment of Microbiology and Immunology, Milton S Hershey Medical Center, The Penn State College of Medicine, Hershey, Pennsylvania 17033, USA.
Emily I McDevitt
Junjia Zhu
Bruce Stanley
Jacek Krzeminski
Shantu Amin
Cesar Aliaga
Thomas G Miller
Harriet C Isom
Institute of Cytochemistry and Molecular Pharmacology · RUPenn State Milton S. Hershey Medical Center · US

Funding

METAL INDUCED INJURY IN HEPATOCYTESR01DK054482 · NIDDK · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI ISOM, HARRIET C. · 1998 to 2006
$2.2M
NIDDK NIH HHS DK54482
6 · The paper itself

Abstract

Hepatic iron overload has been associated classically with the genetic disorder hereditary hemochromatosis. More recently, it has become apparent that mild-to-moderate degrees of elevated hepatic iron stores observed in other liver diseases also have clinical relevance. The goal was to use a mouse model of dietary hepatic iron overload and isobaric tag for relative and absolute quantitation proteomics to identify, at a global level, differentially expressed proteins in livers from mice fed a control or 3,5,5-trimethyl-hexanoyl-ferrocene (TMHF) supplemented diet for 4 weeks. The expression of 74 proteins was altered by ≥ ±1.5-fold, showing that the effects of iron on the liver proteome were extensive. The top canonical pathway altered by TMHF treatment was the NF-E2-related factor 2 (NRF2-)-mediated oxidative stress response. Because of the long-standing association of elevated hepatic iron with oxidative stress, the remainder of the study was focused on NRF2. TMHF treatment upregulated 25 phase I/II and antioxidant proteins previously categorized as NRF2 target gene products. Immunoblot analyses showed that TMHF treatment increased the levels of glutathione S-transferase (GST) M1, GSTM4, glutamate-cysteine ligase (GCL) catalytic subunit, GCL modifier subunit, glutathione synthetase, glutathione reductase, heme oxygenase 1, epoxide hydrolase 1, and NAD(P)H dehydrogenase quinone 1. Immunofluorescence, carried out to determine the cellular localization of NRF2, showed that NRF2 was detected in the nucleus of hepatocytes from TMHF-treated mice and not from control mice. We conclude that elevated hepatic iron in a mouse model activates NRF2, a key regulator of the cellular response to oxidative stress.

Indexed as

AnimalsDisease Models, AnimalFerrous CompoundsHexanolsImmunohistochemistryIronIron OverloadLiverMaleMass SpectrometryMetallocenesMiceMice, Inbred C57BLNF-E2-Related Factor 23,5,5-trimethyl-1-hexanolferroceneFerrous CompoundsHexanolsIronMetallocenesNF-E2-Related Factor 2

Identifiers

PMID22649188
PMCPMC3499080
OpenAlexW2158276158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.